Moderator

Linda Mayes, MD, is the Arnold Gesell Professor of Child Psychiatry, Pediatrics, and Psychology and Director of the Yale Child Study Center. She is also Special Advisor to the Dean in the Yale School of Medicine. Trained as a pediatrician, Dr. Mayes’s research focuses on stress-response and regulatory mechanisms in young children at both biological and psychosocial risk. She has especially focused on the impact of prenatal substance use on children’s long-term outcomes. She has made contributions to understanding the mechanisms of effect of prenatal stimulant exposure on the ontogeny of arousal regulatory systems and the relation between dysfunctional emotional regulation and impaired prefrontal cortical function in young children. She has published widely in the developmental psychology, pediatrics, and child psychiatry literature.

Panelists

• Hilary Hahn, EdM, MPH, is the Executive Director of Elevate Policy Lab and the Mental Health Outreach for MotherS (MOMS) Partnership and a Research Scientist in the Yale Schools of Public Health and Medicine. Hilary spent the early part of her career in the Yale Child Study Center, Center for Traumatic Stress and Recovery, helping to develop, evaluate and disseminate early and brief interventions/mental health treatments. Hilary has always been passionate about the health and well-being of women and families and transitioned to her current position in Spring 2020. Committed to mental health as a key to the health, well-being and resiliency of families, Hilary leads a portfolio of efforts that builds investment in sustainable mental health programming at multiple levels. Ms. Hahn holds advanced degrees in Educational Administration & Social Policy and Public Health.

• Arietta Slade, PhD, is Professor of Clinical Child Psychology at the Yale Child Study Center, and Professor Emerita in the doctoral program in Clinical Psychology at the City University of New York. An internationally recognized theoretician, clinician, researcher, and teacher, she has published widely on reflective parenting, the clinical implications of attachment theory, the development of parental mentalization, and the relational contexts of early symbolization, and regularly presents her work to national and international audiences. For the past 20 years she has been co-directing Minding the Baby, an interdisciplinary reflective parenting home visiting program for high-risk mothers, infants, and their families, at the Yale Child Study Center and School of Nursing. This program is one of only 18 certified “evidence-based” home visiting programs in the United States. 

• Alicia Lieberman, PhD, is the Irving B. Harris Endowed Chair in Infant Mental Health and Vice Chair for Academic Affairs at the UCSF Department of Psychiatry, and Director of the Child Trauma Research Program. She is a clinical consultant with the San Francisco Human Services Agency. She is active in major national organizations involved with mental health in infancy and early childhood. She is past-president of the board of directors of Zero to Three: National Center for Infants, Toddlers and Families, and on the Professional Advisory Board of the Johnson & Johnson Pediatric Institute. She has served on peer review panels of the National Institute of Mental Health, is on the Board of Trustees of the Irving Harris Foundation, and consults with the Miriam and Peter Haas Foundation on early childhood education for Palestinian-Israeli children.

Austen Riggs Center Inc. adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. All those at Austen Riggs Center involved in the planning of this activity, including the presenter(s) listed above, report they have no relevant financial relationships with an ineligible company*.

The views and opinions expressed in this presentation are those of the presenter(s) and do not necessarily represent the official policy or position of the Austen Riggs Center.

* An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.